Olema Oncology to Participate in Upcoming Investor Conferences
Olema Oncology (Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on targeted therapies for breast cancer, has announced its participation in three upcoming investor conferences. The company will attend the Jefferies London Healthcare Conference on November 20, 2024, at 1:30 p.m. GMT, the Evercore HealthCONx Conference on December 3, 2024, at 2:10 p.m. ET, and Citi's Global Healthcare Conference on December 3, 2024, at 3:15 p.m. ET. The events will feature various presentation formats including fireside chats and panel discussions. Live webcasts will be available on Olema's investor relations website and archived for at least 30 days.
Olema Oncology (Nasdaq: OLMA), una società biofarmaceutica in fase clinica focalizzata su terapie mirate per il cancro al seno, ha annunciato la sua partecipazione a tre prossime conferenze per investitori. La società parteciperà alla Jefferies London Healthcare Conference il 20 novembre 2024, alle 13:30 GMT, alla Evercore HealthCONx Conference il 3 dicembre 2024, alle 14:10 ET, e alla Citi's Global Healthcare Conference il 3 dicembre 2024, alle 15:15 ET. Gli eventi presenteranno diversi formati di presentazione, tra cui conversazioni informali e discussioni di gruppo. Le trasmissioni live saranno disponibili sul sito delle relazioni con gli investitori di Olema e archiviate per almeno 30 giorni.
Olema Oncology (Nasdaq: OLMA), una compañía biofarmacéutica en etapa clínica centrada en terapias dirigidas para el cáncer de mama, ha anunciado su participación en tres próximas conferencias para inversores. La empresa asistirá a la Jefferies London Healthcare Conference el 20 de noviembre de 2024, a la 1:30 p.m. GMT, a la Evercore HealthCONx Conference el 3 de diciembre de 2024, a las 2:10 p.m. ET, y a la Citi's Global Healthcare Conference el 3 de diciembre de 2024, a las 3:15 p.m. ET. Los eventos presentarán varios formatos de presentación, incluidos diálogos informales y discusiones en panel. Las transmisiones en vivo estarán disponibles en el sitio web de relaciones con los inversores de Olema y archivadas durante al menos 30 días.
Olema Oncology (Nasdaq: OLMA)는 유방암을 위한 표적 치료에 중점을 둔 임상 단계의 생명공학 회사로, 곧 있을 세 가지 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 2024년 11월 20일 GMT 기준 오후 1시 30분에 열리는 Jefferies London Healthcare Conference, 2024년 12월 3일 ET 기준 오후 2시 10분에 열리는 Evercore HealthCONx Conference, 2024년 12월 3일 ET 기준 오후 3시 15분에 열리는 Citi's Global Healthcare Conference에 참석할 예정입니다. 이 행사에서는 담화 및 패널 토론 등 다양한 발표 형식이 포함됩니다. 생중계는 Olema의 투자자 관계 웹사이트에서 이용 가능하며 최소 30일 동안 아카이브됩니다.
Olema Oncology (Nasdaq: OLMA), une société biopharmaceutique en phase clinique spécialisée dans les thérapies ciblées pour le cancer du sein, a annoncé sa participation à trois conférences pour investisseurs à venir. La société assistera à la Jefferies London Healthcare Conference le 20 novembre 2024 à 13h30 GMT, à la Evercore HealthCONx Conference le 3 décembre 2024 à 14h10 ET, et à la Citi's Global Healthcare Conference le 3 décembre 2024 à 15h15 ET. Les événements comprendront divers formats de présentation, y compris des discussions informelles et des tables rondes. Des webinaires en direct seront disponibles sur le site des relations investisseurs d'Olema et seront archivés pendant au moins 30 jours.
Olema Oncology (Nasdaq: OLMA), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf gezielte Therapien für Brustkrebs konzentriert, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen angekündigt. Das Unternehmen wird an der Jefferies London Healthcare Conference am 20. November 2024 um 13:30 GMT, an der Evercore HealthCONx Conference am 3. Dezember 2024 um 14:10 ET und an der Citi's Global Healthcare Conference am 3. Dezember 2024 um 15:15 ET teilnehmen. Die Veranstaltungen bieten verschiedene Präsentationsformate, darunter Gespräche am Kamin und Podiumsdiskussionen. Live-Webcasts werden auf der Investor-Relations-Website von Olema verfügbar sein und mindestens 30 Tage archiviert.
- None.
- None.
SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that its management team will participate in the following upcoming investor conferences:
Jefferies London Healthcare Conference
Date: Wednesday, November 20, 2024, at 1:30 p.m. GMT (8:30 a.m. ET)
Location: London, UK
Format: Fireside Chat
7th Annual Evercore HealthCONx Conference
Date: Tuesday, December 3, 2024, at 2:10 p.m. ET
Location: Loews Coral Gables Hotel in Coral Gables, FL
Format: Fireside Chat
Citi’s 2024 Global Healthcare Conference
Date: Tuesday, December 3, 2024, at 3:15 p.m. ET
Location: Intercontinental Miami Hotel in Miami, FL
Format: Panel Discussion
Live webcasts of the presentations and any accompanying materials will be available under the News & Events section of Olema’s investor relations website at ir.olema.com. The webcasts will be archived for at least 30 days.
About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for women living with cancer. Olema is advancing a pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance. Our lead product candidate, palazestrant (OP-1250), is a proprietary, orally-available complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD), currently in a Phase 3 clinical trial called OPERA-01. In addition, Olema is developing a potent KAT6 inhibitor (OP-3136). Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts. For more information, please visit us at www.olema.com.
IR and Media Contact
Courtney O’Konek, Vice President, Corporate Communications
media@olema.com
FAQ
What investor conferences will Olema Oncology (OLMA) attend in November and December 2024?
Where can investors watch Olema Oncology's (OLMA) conference presentations?
What time is Olema Oncology's (OLMA) presentation at the Jefferies London Healthcare Conference?
Will Olema Oncology (OLMA) participate in any conferences in Miami during December 2024?
